Revium Rx. (RVRC)
OTCMKTS · Delayed Price · Currency is USD
1.670
+0.170 (11.33%)
At close: Mar 30, 2026
Revium Rx. Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2009 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '09 Dec 31, 2009 |
| - | - | - | - | - | 0.66 | |
Revenue Growth (YoY) | - | - | - | - | - | -77.96% |
Cost of Revenue | - | - | - | - | - | 0.55 |
Gross Profit | - | - | - | - | - | 0.1 |
Selling, General & Admin | 1.57 | 1.82 | 1.41 | 0.16 | 1.12 | 0.21 |
Research & Development | 1.9 | 1.64 | 2.16 | 0.85 | 0.07 | - |
Operating Expenses | 3.47 | 3.46 | 3.57 | 1 | 1.19 | 0.21 |
Operating Income | -3.47 | -3.46 | -3.57 | -1 | -1.19 | -0.1 |
Interest Expense | - | - | -0 | - | -0.02 | - |
Interest & Investment Income | 0.06 | 0.06 | 0.07 | - | - | - |
Other Non Operating Income (Expenses) | -0.09 | - | - | 0.02 | - | - |
EBT Excluding Unusual Items | -3.5 | -3.41 | -3.51 | -0.99 | -1.21 | -0.1 |
Impairment of Goodwill | -8.65 | -8.65 | - | - | - | - |
Asset Writedown | -1.04 | -1.04 | - | - | - | - |
Pretax Income | -13.18 | -13.09 | -3.51 | -0.99 | -1.21 | -0.1 |
Income Tax Expense | 0.36 | 0.36 | - | - | - | - |
Net Income | -13.54 | -13.45 | -3.51 | -0.99 | -1.21 | -0.1 |
Preferred Dividends & Other Adjustments | - | - | - | -0.99 | - | - |
Net Income to Common | -13.54 | -13.45 | -3.51 | - | -1.21 | -0.1 |
Shares Outstanding (Basic) | 61 | 61 | 26 | 29 | 28 | 0 |
Shares Outstanding (Diluted) | 61 | 61 | 26 | 29 | 28 | 0 |
Shares Change (YoY) | 48.92% | 136.92% | -12.69% | 4.44% | 48170.60% | -15.69% |
EPS (Basic) | -0.22 | -0.22 | -0.14 | - | -0.04 | -1.78 |
EPS (Diluted) | -0.22 | -0.22 | -0.14 | - | -0.04 | -1.78 |
Free Cash Flow | -2.72 | -2.54 | -1.21 | -1.02 | -0.82 | 3.23 |
Free Cash Flow Per Share | -0.04 | -0.04 | -0.05 | -0.04 | -0.03 | 55.51 |
Gross Margin | - | - | - | - | - | 15.59% |
Operating Margin | - | - | - | - | - | -15.79% |
Profit Margin | - | - | - | - | - | -15.79% |
Free Cash Flow Margin | - | - | - | - | - | 491.85% |
EBITDA | -3.46 | -3.46 | -3.56 | -1 | -1.19 | - |
D&A For EBITDA | 0.01 | 0.01 | 0 | 0 | 0 | - |
EBIT | -3.47 | -3.46 | -3.57 | -1 | -1.19 | -0.1 |
EBIT Margin | - | - | - | - | - | -15.79% |